Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» drug pricing
drug pricing
After protests, pharma industry reaches 'landmark' drug spending deal with UK government
After protests, pharma industry reaches 'landmark' drug spending deal with UK government
Fierce Pharma
UK
drug pricing
NHS
Flag link:
Cigna's Express Scripts launches cost-based drug pricing model
Cigna's Express Scripts launches cost-based drug pricing model
Investing.com
PBMs
Cigna
Express Scripts
drug pricing
cost-based pricing
Flag link:
Senator floats new models to manage costs of weight loss drugs like Ozempic
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Novo Nordisk
Wegovy
Ozempic
weightloss
Senate
drug pricing
Flag link:
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Bluebird won't play off Vertex in deciding price for its lovo-cel gene therapy, exec says
Fierce Pharma
Bluebird Bio
Vertex Pharmaceuticals
exa-cel
lovo-cel
sickle cell disease
drug pricing
Flag link:
Sen. Bernie Sanders moves toward another hearing with pharma CEOs
Sen. Bernie Sanders moves toward another hearing with pharma CEOs
Stat
Senate
Bernie Sanders
Pharma CEOs
drug pricing
Flag link:
Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
Biogen-Sage Therapeutics postpartum depression pill priced at $15,900
Reuters
Biogen
SAGE Therapeutics
postpartum depression
drug pricing
Zurzuvae
Flag link:
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
HHS Considers Removing J&J’s Stelara from Medicare Drug Price Negotiations
BioSpace
JNJ
Stelara
HHS
Inflation Reduction Act
Medicare
drug pricing
Flag link:
Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid
Pfizer Will Charge Up To $1,400 For Covid Drug Paxlovid
Forbes
Pfizer
Paxlovid
COVID-19
drug pricing
Flag link:
Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
Lilly, AbbVie, BMS and more rally against UK's 'arbitrary' growth cap on branded drug market
Fierce Pharma
UK
drug pricing
ABPI
Flag link:
Oncology Practices May Be Hurt by Medicare Drug Price Negotiations
Oncology Practices May Be Hurt by Medicare Drug Price Negotiations
OBR Oncology
HHS
Medicare
oncologists
drug pricing
Flag link:
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Boehringer Ingelheim embraces dual-pricing tactic with launch of unbranded Humira biosimilar
Fierce Pharma
Boehringer Ingelheim
Cyltezo
biosimilars
Humira
drug pricing
Flag link:
Drugmakers face uphill battle in Medicare negotiation suits
Drugmakers face uphill battle in Medicare negotiation suits
Pharma Voice
Inflation Reduction Act
Medicare
drug pricing
Flag link:
US judge refuses to block Medicare from negotiating drug prices
US judge refuses to block Medicare from negotiating drug prices
Reuters
Medicare
legal
Inflation Reduction Act
drug pricing
Flag link:
Novo Nordisk challenges CMS drug price negotiations, then signs on to the program
Novo Nordisk challenges CMS drug price negotiations, then signs on to the program
Fierce Pharma
Novo Nordisk
CMS
drug pricing
Medicare
Inflation Reduction Act
Flag link:
Senator probes Cleveland Clinic, Bon Secours over 340B program
Senator probes Cleveland Clinic, Bon Secours over 340B program
Beckers Hospital Review
340B
drug pricing
hospitals
Senate
Cleveland Clinic
Flag link:
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
AstraZeneca, BMS Reluctantly Agree to Medicare Drug Price Negotiation Program
BioSpace
AstraZeneca
Bristol Myers Squibb
drug pricing
Inflation Reduction Act
Medicare
Flag link:
The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021
The 340B Program Reached $54 Billion in 2022—Up 22% vs. 2021
Drug Channels
340B
drug pricing
Flag link:
Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox
Revance rolls out a price drop for Daxxify as it tries to challenge AbbVie's Botox
Fierce Pharma
Revance Therapeutics
Daxxify
AbbVie
Botox
drug pricing
Flag link:
DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations
DOJ, Chamber of Commerce Tussle in Court Over IRA’s Drug Price Negotiations
BioSpace
DOJ
Inflation Reduction Act
drug pricing
Medicare
legal
Flag link:
How Payers Are Reacting to Insulin Price Changes
How Payers Are Reacting to Insulin Price Changes
Drug Channels
payers
insurance
insulin
diabetes
drug pricing
Inflation Reduction Act
Medicare
Flag link:
Pages
1
2
3
4
5
6
7
8
9
…
next ›
last »